Goldentree Asset Management LP Has $15.72 Million Stock Holdings in Ardent Health, Inc. $ARDT

Goldentree Asset Management LP trimmed its position in shares of Ardent Health, Inc. (NYSE:ARDTFree Report) by 14.5% during the second quarter, Holdings Channel.com reports. The institutional investor owned 1,153,113 shares of the company’s stock after selling 195,498 shares during the period. Ardent Health accounts for 1.5% of Goldentree Asset Management LP’s investment portfolio, making the stock its 17th largest holding. Goldentree Asset Management LP’s holdings in Ardent Health were worth $15,716,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its position in Ardent Health by 368.9% during the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock worth $18,296,000 after buying an additional 1,046,845 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Ardent Health by 1.4% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 828,611 shares of the company’s stock worth $11,377,000 after purchasing an additional 11,429 shares during the last quarter. SageView Advisory Group LLC boosted its position in shares of Ardent Health by 367.2% in the second quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock valued at $10,800,000 after acquiring an additional 621,430 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Finally, Nuveen LLC bought a new stake in shares of Ardent Health during the 1st quarter valued at $6,010,000.

Ardent Health Trading Down 2.4%

ARDT opened at $8.58 on Tuesday. The company has a market cap of $1.23 billion, a P/E ratio of 5.91, a price-to-earnings-growth ratio of 7.23 and a beta of 0.79. The company has a fifty day moving average price of $12.41 and a two-hundred day moving average price of $12.72. The company has a current ratio of 2.08, a quick ratio of 1.95 and a debt-to-equity ratio of 0.67. Ardent Health, Inc. has a 1-year low of $8.28 and a 1-year high of $17.34.

Ardent Health (NYSE:ARDTGet Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.42 by $0.10. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. Analysts predict that Ardent Health, Inc. will post 1.23 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ARDT shares. Mizuho lowered their price target on Ardent Health from $20.00 to $13.00 and set an “outperform” rating for the company in a report on Tuesday, November 18th. Weiss Ratings restated a “sell (d)” rating on shares of Ardent Health in a research report on Monday, December 1st. Bank of America reduced their price target on Ardent Health from $12.00 to $10.00 and set an “underperform” rating on the stock in a report on Thursday, November 13th. Stephens cut their target price on shares of Ardent Health from $21.00 to $17.00 and set an “overweight” rating on the stock in a research report on Friday, November 14th. Finally, The Goldman Sachs Group initiated coverage on Ardent Health in a report on Tuesday, October 14th. They issued a “neutral” rating and a $19.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $15.00.

View Our Latest Research Report on Ardent Health

About Ardent Health

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Further Reading

Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health, Inc. (NYSE:ARDTFree Report).

Institutional Ownership by Quarter for Ardent Health (NYSE:ARDT)

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.